SlideShare a Scribd company logo
1 of 36
1
2
Presentation Overview
• Cervical cancer 101
– Cause: Human Papilloma Virus (HPV)
– “Natural history”
– Treatment
• Preventing cervical cancer
– Avoiding exposure to HPV
– Current screening guidelines
– The new HPV vaccines
3
Cervical Cancer 101
• Abnormal cell growth on cervix (lowest
part of the uterus)
• Caused by HPV infection, especially
during the first years after puberty
• Pre-cancerous changes long before
invasive cancer develops
• Rarely fatal in this country
• A major cause of death worldwide
4
Human Papillomavirus (HPV)
• Long known to cause warts
• Found in many cancers too
• Over 100 types identified
• Most benign, but 15-20 can
cause cancers
• Very common
– 20,000,000 current cases in US
– 6,200,000 new cases annually
– 80% of women have HPV by age 50
– 50% of college students are infected
5
HPV & Cervical Cancer
• HPV recognized as the underlying cause ofHPV recognized as the underlying cause of
cervical cancer since 1996cervical cancer since 1996
– NIH Consensus Conference on Cervical Cancer,
1996
– World Health Organization/European Research
Organization on Genital Infection and Neoplasia,
1996
6
Common HPV Types and their effects
HPV Types Lead to:
Low-Risk
High-Risk
HPV 6, 11,
40,, 42, 43, 44,
54, 61, 70, 72, 81
HPV 16, 18,
31, 33, 35, 39,
45, 51, 52, 56,
58, 59, 68, 73, 82
Benign cervical changes
Genital warts
Precancer cervical changes
Cervical cancer
Anal and other cancers
1. Cox. Baillière’s Clin Obstet Gynaecol. 1995;9:1.
2. Munoz et al. N Engl J Med. 2003;348:518.
7
Human Papillomavirus
Cancer of cervix 100%
Cancer of esophagus .
Cancer of skin .
Cancer of X,Y,Z…. .
Cancer of mouth 3%
Cancer of throat 12%
Cancer of penis 40%
Cancer of vulva, vagina 40%
Cancer of anus 90%
Parkin DM et al. CA Cancer J Clin 2005; 55:74-108.
8
Natural History of HPV Infections
• Sexually transmitted
• Usually no symptoms
• No treatment for HPV infection before symptoms
• Immune system clears most cases; some persist
• HPV present in >99% of cervical cancers
• High risk types (16, 18) associated with cancer
• Low risk types (6, 11) are associated with genital
warts
• All can cause abnormal Pap tests
Human Papillomavirus. ACOG Practice Bulletin No. 61. 2005; 105: 905-18.
9
Co-factors for HPV Infection
•Smoking
•HIV infection
•Other immune system defect
•Pregnancy
•Oral contraceptive use
Ferris et al. Modern Colposcopy. 2004.
10
HPV and Cervical Cancer Rates
by Age
1. Sellors et al. CMAJ. 2000;163:503.
2. Ries et al. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 1973-1997. 2000.
Age (Years)
HPVPrevalence(%)
40-4415-19 20-24 25-29 30-34 35-39 45-49 50-54
0
5
10
15
20
25
30
0
5
10
15
20
25
30
Cancerincidenceper100,000
11
HPV Infections: Summary
• Most people are infected by HPV at some time
• Immune system usually clears HPV, but not always
• Persistent low-risk HPV can lead to genital warts
• Persistent high-risk HPV can lead to pre-cancer
HPV
Long persistence of HPV can
lead to cancer
12
Preventing Cervical Cancer
• Screening for precancerous changes
(and treatment if problems found)
• Vaccination against HPV
13
History of the Conventional
Pap Smear
• Developed by Dr. George N.
Papanicolaou in 1940’s
• Most common cancer
screening test
• Key part of annual
gynecologic examination
• Has greatly reduced cervical
cancer mortality in U.S.
Ferris et al. Modern Colposcopy. 2004: 2-4, 49.
Photo accessed from http://www.cytology-iac.org/Cytopaths/1998/cytoFall98.htm
14
Screening with the
Conventional Pap Smear
• Widely available
• Inexpensive
• But not perfect
– Screening test – not diagnostic
– 7-10% of women need further evaluation
– Low sensitivity – need regular repeats
Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
15
New Liquid Pap Tests
• More accurate test
– Thin, uniform layer of cells
– Screening errors reduced by
half
• Screening needed less often
• Can test for HPV with same
specimen if abnormal cells
found
• Expensive
Linder J. et al. Arch Pathol Lab Med. 1998; 122: 139-144.
16
Cervical Cancer Screening Guidelines
• First screen 3 years after first
intercourse or by age 21
• Screen annually with regular Paps or
every 2 years with liquid-based tests
• After three normal tests, can go to
every three years
• Stop at 65-70 years with history of
negative tests
• Still need annual check-ups
Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
17
NEW! The HPV Vaccine
Gardasil ® (Merck)
• Protects against types 16, 18, 6, 11
• FDA approved for use in females 9-26 years of age
• Prevents HPV infection; doesn’t treat existing infection
• Virus-like particles (VLP)
• Highly effective
• Safe, few serious adverse side effects
• Requires 3 injections
• Expensive ($360 + administrative fees)
Smith, RA et al. Cancer. 2003;53(1): 27-43.
18
HPV Vaccine
ACOG Recommendations
VACCINATE allVACCINATE all females 9-26 years old,
regardless of sexual activity
• Less potential benefit with increasing age & number of sexual
partners
Special populations – vaccine less effective
• Previous abnormal Pap tests or genital warts
• Immunocompromised
Continue screening with Pap tests!Continue screening with Pap tests!
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
19
NOT CURRENTLY RECOMMENDEDNOT CURRENTLY RECOMMENDED
(Awaiting more evidence)(Awaiting more evidence)
Continue screening with Pap tests!Continue screening with Pap tests!
• Women over age 26
• Pregnant women
– If vaccine started before pregnancy, give
remaining dose(s) post-partum
• Breastfeeding women
• Men
HPV Vaccine
ACOG Recommendations
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
Medical Treatment with Herbs
20
• Habbatussauda (Nigella sativa
Linn/Black Cumin)
Black cumin can cure cancer. Black cumin Medicinal Plants contain
fatty acids that can prevent the growth of cancer cells. And not only
that's just black cumin also has the ability to be able to stimulate the
bone marrow production. Intereron production and can improve the
immune system in the body's cells. and by consuming black cumin then
normal body cells that still can be properly maintained and have the
ability to fight and to kill cancer cells in the body.
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
Medical Treatment with Herbs
21
• Selaginella doederleinii Hieron
Sri Handayani research results SFarm Apt MSi of Chemistry LIPI
Research Center, proving Selaginella doederleinii Hieron
extract can kill breast cancer cells. "The study was the first step in order to
scribble recognized as standardized herbal as required by the Food and
Drug Monitoring Agency (BPOM)," said the alumnus of Gadjah Mada
University.
Furthermore Handayani test the inhibitory concentration (IC) 50 to 96
Selaginellaextract cell cultures of MCF - 7 breast cancer cells resistant
to chemotherapy. IC50 value indicates the level of concentration of the
extract to menghazmbat or shut down 50% of the test cell. The results
showed the IC50 value reaches 61 ug / ml. That is, with a concentration
of 61 ug / ml, chicken claw extract is able to inhibit or shut down 50% of
cancer cells.
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
Medical Treatment with Herbs
22
• Hedyotis corymbosa
Hedyotis corymbosa contains hentriakontane, stikmasterol, ursolic acid,
sitosterol, D-glucoside, p- coun Maric acid, flavonoids glycossides and
oleic acid. Members familli Rubiaceae This is a sweet, slightly bitter,
soft neutral and rather cold. Boondoggle to remove heat and toxic anti-
inflammatory, diuretic, heals ulcers and activate blood circulation.
Lymphosarcoma cancer, gastric cancer, cervix, breast cancer, rectal
cancer, nasopharyngeal cancer: About 50 gr crops washed, then boiled
with 14 cups water to boil, culture up to 2 cups of water, then remove
from heat. When cool, strain the decoction and drink 2 times a day,
each 1 cup.
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
Medical Treatment with Herbs
23
• Andrographis paniculata Ness
CHEMICAL CONTENT: Leaves and branched containing laktone
consisting of deoksiandrografolid, andrographolide (bitter
substances), neoandrografolid, 14-deoxy-11-12-
didehidroandrografolid, and homoandrografolid. Also there are
flavonoids, alkane, ketone, aldehyde, minerals (potassium,
calcium, sodium), acid grit, and resin. Flavotioid isolated most of
the roots, namely polimetoksiflavon, andrografin, pan.ikulin,
mono-0- metilwithin, and apigenin-7,4- dimetileter. The active
substance andrographolide proved efficacious as
hepatoprotektbr (protects liver cells from toxic substances).
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
Medical Treatment with Herbs
24
• Garlic / Aglio
Garlic Herbal Anti-Cancer
Wowwww, at least that's the reaction been discovered by researchers when
researching properties of garlic for the most dangerous disease of
cancer. Garlic is worth mentioning as herbal / plant anti-cancer, contain
allyl sulfides contained in garlic as a herbal anti-cancer causes.
One of the clear evidence that the researchers discovered is the content of
PhIP, one form of heterocyclic amines (HCAs), which are substances
that can trigger breast cancer for women. From various studies
conducted diallyl sulphide substances contained in garlic inhibits the
growth and transformation into a carcinogen PhIP that can eventually
lead to breast cancer.
But you should remember that garlic has anti-cancer agent that is effective
to prevent the growth of cells of various types of cancer that are harmful
to you.
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
25
HPV Vaccine
Important Considerations
Continue screening with Pap tests!Continue screening with Pap tests!
• Vaccine is most effective before first sexual
intercourse – less effective in sexually active
women
• HPV testing before vaccine not
recommended
• Vaccine is not a treatment for current HPV
infection, genital warts, or pre-cancer
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
26
HPV Vaccine FAQ
• Vaccine will not cause HPV
– Virus-like particle vaccine (not live virus)
• HPV vaccines appear to be very safe
– Few major adverse events, but limited data
• Most side effects are minor
– Injection site reaction
• Potentially effective in preventing cervical cancer
(and other HPV-related cancers)
– BUT not all cancer-causing HPV types are covered by the
vaccine
Continue screening with Pap tests!Continue screening with Pap tests!
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
27
HERBS
ANT NESTS HERBAL CAPSULE (DRUG DISEASEANT NESTS HERBAL CAPSULE (DRUG DISEASE
CANCER / TUMOR) HIUCANCER / TUMOR) HIU
BPOM POM TR 133 373 081
• Treating cancer and tumors
• Treating Coronary Heart and various cardiovascular disorders
• Treating Stroke heavy and light,
• Treat Lupus, Ambien (Hemorrhoids) • Eliminate the lumps in the breast
• Troubleshooting kidney and prostate, tuberculosis and lung problems
• Ambien (Hemorrhoids) new and old
• Blood circulation
• Overcoming stiff and sore muscles • Increase vitality • Improve and increase stamina
Composition:
Myrmecodia pendans 100%
ATTENTION!
Not recommended for pregnant women, nursing mothers and children under 2 years
Price Rp. 99.000, - (Excluding Shipping)
Please contoact (For All Herbs Products)
SMS / WA / skype + 62856-4O-53-5O-8I
email / fb: gudangmuslimindo@gmail.com
PIN: D7C0456A
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
28
HERBS
KELADIKAPS simplisia Typhonium flagelliforme Rhizoma CAPSULEKELADIKAPS simplisia Typhonium flagelliforme Rhizoma CAPSULE
EXTRACT (Herbal Cancer Tumor)EXTRACT (Herbal Cancer Tumor)
Contents: 60 capsules
Permits: POM TR 103 310 201
Some recent studies mentioned plants simplisia Typhonium flagelliforme Rhizoma proved to have
efficacy to destroy cancer cells, but it would be difficult to find this plant sanagat let alone cultivate it to
be consumed as a drug. Now comes, the solution easily consume taro mice with the rodent tuber
extract KELADIKAPS.
composition:
simplicia Typhonium flagelliforme Rhizoma (tuber taro rat)
Keladikaps efficacy of rodent tuber extract:
In tradisisonal used for cancer patients
Drinking rules:
Taken 2 times daily morning and afternoon 2 capsules
WARNING !!!!
• Pregnant women are prohibited from taking this medicine.
• After the operation should not immediately drink taro rat, wait 2 weeks.
• The first two days after drinking may be nausea, diarrhea sedikti, black dirt, and lethargic.
Sometimes vomiting or nausea after drinking simplisia Typhonium flagelliforme Rhizoma , put an end
to or subtract.
ATTENTION!
Not recommended for pregnant women, nursing mothers and children under 2 years
Price Rp. 59.900, - (Excluding Shipping fee)
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
29
HERBS
CYSTOGA CV Toga NusantaraCYSTOGA CV Toga Nusantara
(Herbal Overcoming cancer and(Herbal Overcoming cancer and
cysts)cysts)
PRODUCT BRIEF:
Contents: 50 Capsules @ 500 mg
Permit BPOM: POM TR 113 328 011
Composition:
• Curcumae zadoaria rhizome extract 175 mg
• herb Andrographis extract 125 mg
• Gynura Folium 100 mg
• Curcumae Xanthoria rhyzoma extract 100 mg
Drink suggestion:
-Adults 3 x 2 capsules a day, taken 1 hour
before meals
Price Rp. 59.950,-
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
30
HERBS
HERBAL HERBAMED "BENCALANG" ANTI CANCER /HERBAL HERBAMED "BENCALANG" ANTI CANCER /
TUMORTUMOR
1 Pack Contains 2 Bottle @ 50 capsules @ 250mg
Permit BPOM: POM TR. 103 310 911
Ben Ca Lang, with 2 Bottles, Efficacy of more than 2 x. EXTRAORDINARY!
In 1 Package Ben Ca Lang, there are two bottles of herbal capsules Ben Ca Lang Herbamed
1. Ben Ca Lang Cancer
Composition:
Each capsule contains extracts:
1.) Thyponium Flagelliforme 50 mg 2.) CentellaAsiatica 40 mg 3.) Androgs 35 mg 4.) Merremia
Raphis Panic 40 mg 5.) LoranthuMammosa 30 mg 6.) Curcumae zedoaria 30 mg 7.) Gynura
Precumbents 25 mg
benefit
1. Helps Turn off the cancer cells by splitting the nucleus of cancer cells
2. Inhibit the growth and spread of cancer cells
3. To revitalize the entire network and spread of cancer cells
4. Improving the body's cells
5. Increase endurance and stamina
MUST BE CONSIDERED!
Ben Ca Lang cancer must be taken together with Ben Ca Lang Angion
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
31
HERBS
HERBAL HERBAMED "BENCALANG" ANTI CANCER /HERBAL HERBAMED "BENCALANG" ANTI CANCER /
TUMORTUMOR
11 Pack Contains 2 Bottle @ 50 capsules @ 250mg
Permit BPOM: POM TR. 103 310 911
In 1 Package Ben Ca Lang, there are two bottles of herbal capsules Ben Ca Lang
Herbamed
MUST BE CONSIDERED!
Ben Ca Lang cancer must be taken together with Ben Ca Lang Angion
Ben Ca Lang Angion
Composition
Each capsule contains extracts:
1.) Arecha catechu 50 mg 2.) Phyllanthus urinary 38 mg 3.) Catharanthus roseus 50
mg 4.) Ganoderma Lucidum 38 mg 5.) Eleuthorine Americana 74 mg
property
1. Stopping the formation of new blood vessels, without blood cells, tumor cells /
cancer will die
2. Destroying cancer cells
3. Preventing the cancer cell division
4. Inhibits cancer cell growth
5. Strengthening the immune system
How to use
3 x 3 capsules / day. 30 minutes before meals (Price Rp. 175.000,-)
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
32
HERBS
ALBIMOR Al Biruni (Herbs for Cancer / Tumor)ALBIMOR Al Biruni (Herbs for Cancer / Tumor)
Contents: 50 Capsules
Permit BPOM: POM TR. 103 309 941
COMPOSITION:
• Nigella sativa, Selaginella doederleinii, Hedyotis corymbosa, Andrographis paniculata, etc.
Recommendation:
Reduce consumption of bean sprouts, longan, jackfruit, MSG, durian, tape, pineapple, soft drinks,
ice, chicory, kale, chili, salt, salted fish, and avoid alcohol.
Not for pregnant women and children
DESCRIPTION:
Benefits:
• Killing cancer cells
• Inhibit the growth of cancer cells
• Increase endurance
• Reduces pain from cancer
• Strengthening the tissue cells around the cancer
• Reducing the adverse effects of chemotherapy
Rp. 69.100,-
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
33
HERBS
GARLIC OIL CAPSULES (OIL ONION)GARLIC OIL CAPSULES (OIL ONION)
Composition:
Made from 100% garlic oil
Contents: 60 capsules
MOH license: No. IKOT 442/1077-KES / V / 10
Which has properties as:
• Helps boost immunity
• Overcoming headaches
• Overcoming fever
• Flu
• Indigestion
• Antiseptic
• Antibiotics
• Antimicrobials
• Stroke
• Heart
• Anti-tumor / cancer
• Potent Antioxidant...
Price Rp. 61.000,-
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
34
References
Advisory Committee on Immunization Practices. ACIP provisional recommendations for the use of quadrivalent HPV vaccine.
August 14, 2006. Accessed from http://www.cdc.gov/nip/recs/provisional_recs/hpv.pdf.
American Cancer Society. Cancer facts and figures 2003. Atlanta (GA): ACS 2003. Available at
http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf.
Apgar BS, et al. “The 2001 Bethesda System Terminology.” Am Fam Physician. 2003;68:1992–1998.
Cannistra SA, Niloff JM. “Cancer of the Uterine Cervix.” N Engl J Med. 1996;334:1030–1038.
Cates W Jr, and the American Social Health Association Panel. “Estimates of the incidence and prevalence of sexually
transmitted diseases in the United States.” Sex Transm Dis. 1999;26(suppl):S2–S7.
Centers for Disease Control and Prevention. Rockville, Md: CDC National Prevention Information Network; 2004.
Cervical Cytology Screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet
Gynecol 2003; 102:417-27.
Cox. Baillière’s Clin Obstet Gynaecol. 1995;9:1.
Ferris et al. Modern Colposcopy: Textbook and Atlas. 2nd ed. Dubuque, Iowa: Kendall/Hunt; 2004: 2-4, 49, 78-82.
Howley PM. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia, Pa: Lippincott-Raven;
2001:2197–2229.
Human Papillomavirus. ACOG Practice Bulletin No. 61. American College of Obstetricians and Gynecologists. Obstet
Gynecol 2005; 105: 905-18.
Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. American College of Obstetricians and
Gynecologists. Obstet Gynecol 2006; 108: 699-705.
Hutchinson ML. et al. “Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep
Processor.” Am J Clin Pathol. 1994; 101:215-219.
Jansen KU, Shaw AR. ”Human Papillomavirus Vaccines and prevention of cervical cancer.” Annu Rev Med. 2004;55:319–
331.
Kodner CM, Nasraty S. “Management of genital warts.” Am Fam Physician. 2004;70:2335–2342.
Lacey CJN. “Therapy for genital human papillomavirus-related disease.” J Clin Virol. 2005;32(suppl):S82–S90.
Linder J. et al. “ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.”Arch Pathol Lab Med. 1998; 122:
139-144.
Management of Abnormal Cervical Cytology and Histology. ACOG Practice Bulletin No. 66. American College of
Obstetricians and Gynecologists. Obstet Gynecol 2005; 106: 645-64.
Maw RD, Reitano M, Roy M. “An international survey of patients with genital warts: perceptions regarding treatment and
impact on lifestyle.” Int J STD AIDS. 1998;9:571–578.
35
References (Cont.)
McCrory DC, Matchar DB, Bastian L, et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment
No. 5. AHCPR Publication No. 99-E010. Rockville, MD: Agency for Health Care Policy and Research. February
1999.
Moscicki, A.B. et al. “Updating the natural history of HPV and anogenital cancer.” Vaccine. 2006; 24S3; 42-51.
Munoz et al. “Epidemiologic classification of human papillomavirus types associated with cervical cancer.” N Engl J
Med. 2003;348:518.
Ostor, AG. “Natural history of cervical intraepithelial neoplasia: a critical review.” Int J Gynecol Pathol 1993; 12(2): 186-
92.
Parkin DM, Bray F, Ferlay J, Pisani P. “Global cancer statistics 2002.” CA Cancer J Clin 2005; 55:74-108.
Ries et al. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 1973-1997. 2000.
Saslow D et al. “American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer.” CA
Cancer J Clin. 2002;52:342-362.
Schiffman M, Castle PE. “Human papillomavirus: Epidemiology and public health.” Arch Pathol Lab Med.
2003;127:930–934.
Schiffman M ASCCP 2002 Biennial Orlando, Fl.
Sellors et al. “Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada.” CMAJ.
2000;163:503-8.
Smith, RA et al. “American Cancer Society Guidelines for the Early Detection of Cancer, 2003.” Cancer. 2003;53(1):
27-43.
Solomon D, Davey D, Kurman R, et al, for the Forum Group Members and the Bethesda 2001 Workshop. JAMA.
2002;287:2114–2119.
Soper DE. In: Berek JS, ed. Novak’s Gynecology. 13th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:453–
470.
Spitzer M, Johnson C. Philadelphia, Pa: WB Saunders Co; 2002:41–72.
Wiley DJ, Douglas J, Beutner K, et al “External genital warts: diagnosis, treatment and prevention.” Clin Infect Dis.
2002;35(suppl 2):S210–S224.
Winer RL et al. “Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university
students.” Am J Epidemiol. 2003; 157:218-226.
Wright, T.C. et al. “2001 Consensus Guidelines for the Management of Women with Cervical Cytological
Abnormalities.” JAMA. 2002; 287: 2120-2129.
USPSTF. 2003. Available at http://www.ahrq.gov/clinic/uspstf/uspscerv.htm.
36
Questions?
Program sponsored by
Middle Earth
Slide set developed with help from
Dr. Kim Noyes
Preventive Medicine Resident, School of Public Health
Information provided by the New York State Department of Health,
Cancer Services Program
Please take a few momentsPlease take a few moments
to complete the evaluation!to complete the evaluation!

More Related Content

What's hot

HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER ABHIJIT BANIK
 
HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain Lifecare Centre
 
Recent updates in hpv vaccines
Recent updates in hpv vaccinesRecent updates in hpv vaccines
Recent updates in hpv vaccinesDr. Sunaina Wadhwa
 
CERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTIONCERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTIONO. E.Nyandi PhD
 
Primary High Risk HPV Testing with Cyctology Triage
Primary High Risk HPV Testing with Cyctology TriagePrimary High Risk HPV Testing with Cyctology Triage
Primary High Risk HPV Testing with Cyctology TriagePHEScreening
 
Cervical cancer global burden and where do we stand today
Cervical cancer   global burden and where do we stand todayCervical cancer   global burden and where do we stand today
Cervical cancer global burden and where do we stand todayNiranjan Chavan
 
cervical cancer presentation
cervical cancer presentation cervical cancer presentation
cervical cancer presentation alaaag
 
Vulval Cancer Diagnosis and Staging
Vulval Cancer Diagnosis and StagingVulval Cancer Diagnosis and Staging
Vulval Cancer Diagnosis and StagingDr.Bhavin Vadodariya
 
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Theresa Lowry-Lehnen
 
Cervical cancer prevention Dr Sharda Jain
Cervical cancer prevention Dr Sharda Jain Cervical cancer prevention Dr Sharda Jain
Cervical cancer prevention Dr Sharda Jain Lifecare Centre
 
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain Lifecare Centre
 
Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer  Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer Lifecare Centre
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screeningsarahmccorm
 
Cervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccinationCervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccinationSunita Yadav
 
Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Ules Abraham
 
premalignant lesions of cervix.pptx
premalignant  lesions of cervix.pptxpremalignant  lesions of cervix.pptx
premalignant lesions of cervix.pptxsarath267362
 

What's hot (20)

HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
HUMAN PAPILLOMA VIRUS INFECTION & CERVICAL CANCER
 
HPV vaccination against Cervical Cancer
HPV vaccination against Cervical CancerHPV vaccination against Cervical Cancer
HPV vaccination against Cervical Cancer
 
Hpv
HpvHpv
Hpv
 
HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain
 
Recent updates in hpv vaccines
Recent updates in hpv vaccinesRecent updates in hpv vaccines
Recent updates in hpv vaccines
 
CERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTIONCERVICAL CANCER & ITS PREVENTION
CERVICAL CANCER & ITS PREVENTION
 
Primary High Risk HPV Testing with Cyctology Triage
Primary High Risk HPV Testing with Cyctology TriagePrimary High Risk HPV Testing with Cyctology Triage
Primary High Risk HPV Testing with Cyctology Triage
 
Cervical cancer global burden and where do we stand today
Cervical cancer   global burden and where do we stand todayCervical cancer   global burden and where do we stand today
Cervical cancer global burden and where do we stand today
 
cervical cancer presentation
cervical cancer presentation cervical cancer presentation
cervical cancer presentation
 
Vulval Cancer Diagnosis and Staging
Vulval Cancer Diagnosis and StagingVulval Cancer Diagnosis and Staging
Vulval Cancer Diagnosis and Staging
 
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
 
Cervical cancer prevention Dr Sharda Jain
Cervical cancer prevention Dr Sharda Jain Cervical cancer prevention Dr Sharda Jain
Cervical cancer prevention Dr Sharda Jain
 
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain
GARDASIL 9* FREQUENTLY ASKED QUESTIONS : Dr Sharda Jain
 
Human papillomavirus infection and cervical cancer.
Human papillomavirus infection and cervical cancer.Human papillomavirus infection and cervical cancer.
Human papillomavirus infection and cervical cancer.
 
Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer  Evidence Based Guide of Screening for Prevention of Cervical Cancer
Evidence Based Guide of Screening for Prevention of Cervical Cancer
 
Cervical cancer
Cervical cancer Cervical cancer
Cervical cancer
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screening
 
Cervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccinationCervical cancer screening and hpv vaccination
Cervical cancer screening and hpv vaccination
 
Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Cervical cancer hpv-feb07
Cervical cancer hpv-feb07
 
premalignant lesions of cervix.pptx
premalignant  lesions of cervix.pptxpremalignant  lesions of cervix.pptx
premalignant lesions of cervix.pptx
 

Viewers also liked

HPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: MechanismsHPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: Mechanismsbrandolina1
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virusdrsubir
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentationrinki singh
 
Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awarenessdharshinee-shri
 
Cervical cancer and viral etiology
Cervical cancer and viral etiology Cervical cancer and viral etiology
Cervical cancer and viral etiology kanthasamy
 
Hpv virus infections and oropharynx cancer
Hpv virus infections and oropharynx cancerHpv virus infections and oropharynx cancer
Hpv virus infections and oropharynx cancerRobert J Miller MD
 
cervical cancer presentation
cervical cancer presentationcervical cancer presentation
cervical cancer presentationJoy Awale
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancerraj kumar
 
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre Lifecare Centre
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Lifecare Centre
 
Stroke Overview - EM Orientation
Stroke Overview - EM OrientationStroke Overview - EM Orientation
Stroke Overview - EM OrientationDavid Marcus
 
Human Papiiloma Virus
Human Papiiloma VirusHuman Papiiloma Virus
Human Papiiloma Virusahmedicine
 
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...Alberto Cuadrado
 
Cervical Cancer Presentation from Research india...
Cervical Cancer Presentation from Research india...Cervical Cancer Presentation from Research india...
Cervical Cancer Presentation from Research india...sudhpriya
 

Viewers also liked (20)

HPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: MechanismsHPV and Cervical Cancer: Mechanisms
HPV and Cervical Cancer: Mechanisms
 
Human Papilloma Virus
Human Papilloma VirusHuman Papilloma Virus
Human Papilloma Virus
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentation
 
Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer ppt
 
HPV
HPVHPV
HPV
 
Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awareness
 
Cervical ca
Cervical caCervical ca
Cervical ca
 
Cervical cancer and viral etiology
Cervical cancer and viral etiology Cervical cancer and viral etiology
Cervical cancer and viral etiology
 
Hpv virus infections and oropharynx cancer
Hpv virus infections and oropharynx cancerHpv virus infections and oropharynx cancer
Hpv virus infections and oropharynx cancer
 
cervical cancer presentation
cervical cancer presentationcervical cancer presentation
cervical cancer presentation
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Cervical Cancer 101
Cervical Cancer 101Cervical Cancer 101
Cervical Cancer 101
 
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
 
Stroke Overview - EM Orientation
Stroke Overview - EM OrientationStroke Overview - EM Orientation
Stroke Overview - EM Orientation
 
herpesvirus
herpesvirusherpesvirus
herpesvirus
 
Human Papiiloma Virus
Human Papiiloma VirusHuman Papiiloma Virus
Human Papiiloma Virus
 
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
 
Cervical Cancer Presentation from Research india...
Cervical Cancer Presentation from Research india...Cervical Cancer Presentation from Research india...
Cervical Cancer Presentation from Research india...
 

Similar to Cervical cancer hpv

Hpv and cancers
Hpv and cancersHpv and cancers
Hpv and cancersDIVYA JAIN
 
CERVICAL-CANCER-introduction, screening and prevention
CERVICAL-CANCER-introduction, screening and preventionCERVICAL-CANCER-introduction, screening and prevention
CERVICAL-CANCER-introduction, screening and preventionssuser002e70
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxAmin Badamosi
 
Hpv vaccination gpsnew
Hpv vaccination gpsnewHpv vaccination gpsnew
Hpv vaccination gpsnewDebbie Lewis
 
screening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptscreening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptPriyankaSinha406376
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
 
Cervavac_Speaker_Set_1.pptx
Cervavac_Speaker_Set_1.pptxCervavac_Speaker_Set_1.pptx
Cervavac_Speaker_Set_1.pptxPoonamJhamb3
 
Cervical cancer screening modalities
Cervical cancer screening modalitiesCervical cancer screening modalities
Cervical cancer screening modalitieschaimingcheng
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...Lifecare Centre
 
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.alka mukherjee
 
Multipex for papillomavirus
Multipex for papillomavirusMultipex for papillomavirus
Multipex for papillomavirusPathKind Labs
 
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and Treatment
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and TreatmentAnal Cancer - What's the Bottom Line on Vaccination, Screenings, and Treatment
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and TreatmentTheSurgeryGroupofLA
 
Ca cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGINGCa cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGINGAnuj Sharma
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedManinder Ahuja
 
Vaccineforwomencorrected DR Sharda Jain
Vaccineforwomencorrected DR Sharda Jain Vaccineforwomencorrected DR Sharda Jain
Vaccineforwomencorrected DR Sharda Jain Lifecare Centre
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awarenessdrmcbansal
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness drmcbansal
 
18- dr. ghazi alsbeih kau 13 may 2015
 18- dr. ghazi alsbeih kau 13 may 2015 18- dr. ghazi alsbeih kau 13 may 2015
18- dr. ghazi alsbeih kau 13 may 2015Basalama Ali
 

Similar to Cervical cancer hpv (20)

Hpv and cancers
Hpv and cancersHpv and cancers
Hpv and cancers
 
Human papiloma virus
Human papiloma virusHuman papiloma virus
Human papiloma virus
 
CERVICAL-CANCER-introduction, screening and prevention
CERVICAL-CANCER-introduction, screening and preventionCERVICAL-CANCER-introduction, screening and prevention
CERVICAL-CANCER-introduction, screening and prevention
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptx
 
Hpv vaccination gpsnew
Hpv vaccination gpsnewHpv vaccination gpsnew
Hpv vaccination gpsnew
 
HPV
HPVHPV
HPV
 
screening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.pptscreening_and_prevention protocols for_cervix.ppt
screening_and_prevention protocols for_cervix.ppt
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Cervavac_Speaker_Set_1.pptx
Cervavac_Speaker_Set_1.pptxCervavac_Speaker_Set_1.pptx
Cervavac_Speaker_Set_1.pptx
 
Cervical cancer screening modalities
Cervical cancer screening modalitiesCervical cancer screening modalities
Cervical cancer screening modalities
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
 
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
Cervical cancer by dr alka mukherjee dr apurva mukherjee nagpur m.s.
 
Multipex for papillomavirus
Multipex for papillomavirusMultipex for papillomavirus
Multipex for papillomavirus
 
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and Treatment
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and TreatmentAnal Cancer - What's the Bottom Line on Vaccination, Screenings, and Treatment
Anal Cancer - What's the Bottom Line on Vaccination, Screenings, and Treatment
 
Ca cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGINGCa cervix REVISED FIGO STAGING
Ca cervix REVISED FIGO STAGING
 
Nulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies editedNulife module 6 screening for malignancies edited
Nulife module 6 screening for malignancies edited
 
Vaccineforwomencorrected DR Sharda Jain
Vaccineforwomencorrected DR Sharda Jain Vaccineforwomencorrected DR Sharda Jain
Vaccineforwomencorrected DR Sharda Jain
 
Presentation for public awareness
Presentation for public awarenessPresentation for public awareness
Presentation for public awareness
 
Presentation for public awareness
Presentation for public awareness Presentation for public awareness
Presentation for public awareness
 
18- dr. ghazi alsbeih kau 13 may 2015
 18- dr. ghazi alsbeih kau 13 may 2015 18- dr. ghazi alsbeih kau 13 may 2015
18- dr. ghazi alsbeih kau 13 may 2015
 

Recently uploaded

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 

Recently uploaded (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 

Cervical cancer hpv

  • 1. 1
  • 2. 2 Presentation Overview • Cervical cancer 101 – Cause: Human Papilloma Virus (HPV) – “Natural history” – Treatment • Preventing cervical cancer – Avoiding exposure to HPV – Current screening guidelines – The new HPV vaccines
  • 3. 3 Cervical Cancer 101 • Abnormal cell growth on cervix (lowest part of the uterus) • Caused by HPV infection, especially during the first years after puberty • Pre-cancerous changes long before invasive cancer develops • Rarely fatal in this country • A major cause of death worldwide
  • 4. 4 Human Papillomavirus (HPV) • Long known to cause warts • Found in many cancers too • Over 100 types identified • Most benign, but 15-20 can cause cancers • Very common – 20,000,000 current cases in US – 6,200,000 new cases annually – 80% of women have HPV by age 50 – 50% of college students are infected
  • 5. 5 HPV & Cervical Cancer • HPV recognized as the underlying cause ofHPV recognized as the underlying cause of cervical cancer since 1996cervical cancer since 1996 – NIH Consensus Conference on Cervical Cancer, 1996 – World Health Organization/European Research Organization on Genital Infection and Neoplasia, 1996
  • 6. 6 Common HPV Types and their effects HPV Types Lead to: Low-Risk High-Risk HPV 6, 11, 40,, 42, 43, 44, 54, 61, 70, 72, 81 HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82 Benign cervical changes Genital warts Precancer cervical changes Cervical cancer Anal and other cancers 1. Cox. Baillière’s Clin Obstet Gynaecol. 1995;9:1. 2. Munoz et al. N Engl J Med. 2003;348:518.
  • 7. 7 Human Papillomavirus Cancer of cervix 100% Cancer of esophagus . Cancer of skin . Cancer of X,Y,Z…. . Cancer of mouth 3% Cancer of throat 12% Cancer of penis 40% Cancer of vulva, vagina 40% Cancer of anus 90% Parkin DM et al. CA Cancer J Clin 2005; 55:74-108.
  • 8. 8 Natural History of HPV Infections • Sexually transmitted • Usually no symptoms • No treatment for HPV infection before symptoms • Immune system clears most cases; some persist • HPV present in >99% of cervical cancers • High risk types (16, 18) associated with cancer • Low risk types (6, 11) are associated with genital warts • All can cause abnormal Pap tests Human Papillomavirus. ACOG Practice Bulletin No. 61. 2005; 105: 905-18.
  • 9. 9 Co-factors for HPV Infection •Smoking •HIV infection •Other immune system defect •Pregnancy •Oral contraceptive use Ferris et al. Modern Colposcopy. 2004.
  • 10. 10 HPV and Cervical Cancer Rates by Age 1. Sellors et al. CMAJ. 2000;163:503. 2. Ries et al. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 1973-1997. 2000. Age (Years) HPVPrevalence(%) 40-4415-19 20-24 25-29 30-34 35-39 45-49 50-54 0 5 10 15 20 25 30 0 5 10 15 20 25 30 Cancerincidenceper100,000
  • 11. 11 HPV Infections: Summary • Most people are infected by HPV at some time • Immune system usually clears HPV, but not always • Persistent low-risk HPV can lead to genital warts • Persistent high-risk HPV can lead to pre-cancer HPV Long persistence of HPV can lead to cancer
  • 12. 12 Preventing Cervical Cancer • Screening for precancerous changes (and treatment if problems found) • Vaccination against HPV
  • 13. 13 History of the Conventional Pap Smear • Developed by Dr. George N. Papanicolaou in 1940’s • Most common cancer screening test • Key part of annual gynecologic examination • Has greatly reduced cervical cancer mortality in U.S. Ferris et al. Modern Colposcopy. 2004: 2-4, 49. Photo accessed from http://www.cytology-iac.org/Cytopaths/1998/cytoFall98.htm
  • 14. 14 Screening with the Conventional Pap Smear • Widely available • Inexpensive • But not perfect – Screening test – not diagnostic – 7-10% of women need further evaluation – Low sensitivity – need regular repeats Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
  • 15. 15 New Liquid Pap Tests • More accurate test – Thin, uniform layer of cells – Screening errors reduced by half • Screening needed less often • Can test for HPV with same specimen if abnormal cells found • Expensive Linder J. et al. Arch Pathol Lab Med. 1998; 122: 139-144.
  • 16. 16 Cervical Cancer Screening Guidelines • First screen 3 years after first intercourse or by age 21 • Screen annually with regular Paps or every 2 years with liquid-based tests • After three normal tests, can go to every three years • Stop at 65-70 years with history of negative tests • Still need annual check-ups Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
  • 17. 17 NEW! The HPV Vaccine Gardasil ® (Merck) • Protects against types 16, 18, 6, 11 • FDA approved for use in females 9-26 years of age • Prevents HPV infection; doesn’t treat existing infection • Virus-like particles (VLP) • Highly effective • Safe, few serious adverse side effects • Requires 3 injections • Expensive ($360 + administrative fees) Smith, RA et al. Cancer. 2003;53(1): 27-43.
  • 18. 18 HPV Vaccine ACOG Recommendations VACCINATE allVACCINATE all females 9-26 years old, regardless of sexual activity • Less potential benefit with increasing age & number of sexual partners Special populations – vaccine less effective • Previous abnormal Pap tests or genital warts • Immunocompromised Continue screening with Pap tests!Continue screening with Pap tests! Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 19. 19 NOT CURRENTLY RECOMMENDEDNOT CURRENTLY RECOMMENDED (Awaiting more evidence)(Awaiting more evidence) Continue screening with Pap tests!Continue screening with Pap tests! • Women over age 26 • Pregnant women – If vaccine started before pregnancy, give remaining dose(s) post-partum • Breastfeeding women • Men HPV Vaccine ACOG Recommendations Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 20. Medical Treatment with Herbs 20 • Habbatussauda (Nigella sativa Linn/Black Cumin) Black cumin can cure cancer. Black cumin Medicinal Plants contain fatty acids that can prevent the growth of cancer cells. And not only that's just black cumin also has the ability to be able to stimulate the bone marrow production. Intereron production and can improve the immune system in the body's cells. and by consuming black cumin then normal body cells that still can be properly maintained and have the ability to fight and to kill cancer cells in the body. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 21. Medical Treatment with Herbs 21 • Selaginella doederleinii Hieron Sri Handayani research results SFarm Apt MSi of Chemistry LIPI Research Center, proving Selaginella doederleinii Hieron extract can kill breast cancer cells. "The study was the first step in order to scribble recognized as standardized herbal as required by the Food and Drug Monitoring Agency (BPOM)," said the alumnus of Gadjah Mada University. Furthermore Handayani test the inhibitory concentration (IC) 50 to 96 Selaginellaextract cell cultures of MCF - 7 breast cancer cells resistant to chemotherapy. IC50 value indicates the level of concentration of the extract to menghazmbat or shut down 50% of the test cell. The results showed the IC50 value reaches 61 ug / ml. That is, with a concentration of 61 ug / ml, chicken claw extract is able to inhibit or shut down 50% of cancer cells. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 22. Medical Treatment with Herbs 22 • Hedyotis corymbosa Hedyotis corymbosa contains hentriakontane, stikmasterol, ursolic acid, sitosterol, D-glucoside, p- coun Maric acid, flavonoids glycossides and oleic acid. Members familli Rubiaceae This is a sweet, slightly bitter, soft neutral and rather cold. Boondoggle to remove heat and toxic anti- inflammatory, diuretic, heals ulcers and activate blood circulation. Lymphosarcoma cancer, gastric cancer, cervix, breast cancer, rectal cancer, nasopharyngeal cancer: About 50 gr crops washed, then boiled with 14 cups water to boil, culture up to 2 cups of water, then remove from heat. When cool, strain the decoction and drink 2 times a day, each 1 cup. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 23. Medical Treatment with Herbs 23 • Andrographis paniculata Ness CHEMICAL CONTENT: Leaves and branched containing laktone consisting of deoksiandrografolid, andrographolide (bitter substances), neoandrografolid, 14-deoxy-11-12- didehidroandrografolid, and homoandrografolid. Also there are flavonoids, alkane, ketone, aldehyde, minerals (potassium, calcium, sodium), acid grit, and resin. Flavotioid isolated most of the roots, namely polimetoksiflavon, andrografin, pan.ikulin, mono-0- metilwithin, and apigenin-7,4- dimetileter. The active substance andrographolide proved efficacious as hepatoprotektbr (protects liver cells from toxic substances). Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 24. Medical Treatment with Herbs 24 • Garlic / Aglio Garlic Herbal Anti-Cancer Wowwww, at least that's the reaction been discovered by researchers when researching properties of garlic for the most dangerous disease of cancer. Garlic is worth mentioning as herbal / plant anti-cancer, contain allyl sulfides contained in garlic as a herbal anti-cancer causes. One of the clear evidence that the researchers discovered is the content of PhIP, one form of heterocyclic amines (HCAs), which are substances that can trigger breast cancer for women. From various studies conducted diallyl sulphide substances contained in garlic inhibits the growth and transformation into a carcinogen PhIP that can eventually lead to breast cancer. But you should remember that garlic has anti-cancer agent that is effective to prevent the growth of cells of various types of cancer that are harmful to you. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 25. 25 HPV Vaccine Important Considerations Continue screening with Pap tests!Continue screening with Pap tests! • Vaccine is most effective before first sexual intercourse – less effective in sexually active women • HPV testing before vaccine not recommended • Vaccine is not a treatment for current HPV infection, genital warts, or pre-cancer Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 26. 26 HPV Vaccine FAQ • Vaccine will not cause HPV – Virus-like particle vaccine (not live virus) • HPV vaccines appear to be very safe – Few major adverse events, but limited data • Most side effects are minor – Injection site reaction • Potentially effective in preventing cervical cancer (and other HPV-related cancers) – BUT not all cancer-causing HPV types are covered by the vaccine Continue screening with Pap tests!Continue screening with Pap tests! Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 27. 27 HERBS ANT NESTS HERBAL CAPSULE (DRUG DISEASEANT NESTS HERBAL CAPSULE (DRUG DISEASE CANCER / TUMOR) HIUCANCER / TUMOR) HIU BPOM POM TR 133 373 081 • Treating cancer and tumors • Treating Coronary Heart and various cardiovascular disorders • Treating Stroke heavy and light, • Treat Lupus, Ambien (Hemorrhoids) • Eliminate the lumps in the breast • Troubleshooting kidney and prostate, tuberculosis and lung problems • Ambien (Hemorrhoids) new and old • Blood circulation • Overcoming stiff and sore muscles • Increase vitality • Improve and increase stamina Composition: Myrmecodia pendans 100% ATTENTION! Not recommended for pregnant women, nursing mothers and children under 2 years Price Rp. 99.000, - (Excluding Shipping) Please contoact (For All Herbs Products) SMS / WA / skype + 62856-4O-53-5O-8I email / fb: gudangmuslimindo@gmail.com PIN: D7C0456A Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 28. 28 HERBS KELADIKAPS simplisia Typhonium flagelliforme Rhizoma CAPSULEKELADIKAPS simplisia Typhonium flagelliforme Rhizoma CAPSULE EXTRACT (Herbal Cancer Tumor)EXTRACT (Herbal Cancer Tumor) Contents: 60 capsules Permits: POM TR 103 310 201 Some recent studies mentioned plants simplisia Typhonium flagelliforme Rhizoma proved to have efficacy to destroy cancer cells, but it would be difficult to find this plant sanagat let alone cultivate it to be consumed as a drug. Now comes, the solution easily consume taro mice with the rodent tuber extract KELADIKAPS. composition: simplicia Typhonium flagelliforme Rhizoma (tuber taro rat) Keladikaps efficacy of rodent tuber extract: In tradisisonal used for cancer patients Drinking rules: Taken 2 times daily morning and afternoon 2 capsules WARNING !!!! • Pregnant women are prohibited from taking this medicine. • After the operation should not immediately drink taro rat, wait 2 weeks. • The first two days after drinking may be nausea, diarrhea sedikti, black dirt, and lethargic. Sometimes vomiting or nausea after drinking simplisia Typhonium flagelliforme Rhizoma , put an end to or subtract. ATTENTION! Not recommended for pregnant women, nursing mothers and children under 2 years Price Rp. 59.900, - (Excluding Shipping fee) Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 29. 29 HERBS CYSTOGA CV Toga NusantaraCYSTOGA CV Toga Nusantara (Herbal Overcoming cancer and(Herbal Overcoming cancer and cysts)cysts) PRODUCT BRIEF: Contents: 50 Capsules @ 500 mg Permit BPOM: POM TR 113 328 011 Composition: • Curcumae zadoaria rhizome extract 175 mg • herb Andrographis extract 125 mg • Gynura Folium 100 mg • Curcumae Xanthoria rhyzoma extract 100 mg Drink suggestion: -Adults 3 x 2 capsules a day, taken 1 hour before meals Price Rp. 59.950,- Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 30. 30 HERBS HERBAL HERBAMED "BENCALANG" ANTI CANCER /HERBAL HERBAMED "BENCALANG" ANTI CANCER / TUMORTUMOR 1 Pack Contains 2 Bottle @ 50 capsules @ 250mg Permit BPOM: POM TR. 103 310 911 Ben Ca Lang, with 2 Bottles, Efficacy of more than 2 x. EXTRAORDINARY! In 1 Package Ben Ca Lang, there are two bottles of herbal capsules Ben Ca Lang Herbamed 1. Ben Ca Lang Cancer Composition: Each capsule contains extracts: 1.) Thyponium Flagelliforme 50 mg 2.) CentellaAsiatica 40 mg 3.) Androgs 35 mg 4.) Merremia Raphis Panic 40 mg 5.) LoranthuMammosa 30 mg 6.) Curcumae zedoaria 30 mg 7.) Gynura Precumbents 25 mg benefit 1. Helps Turn off the cancer cells by splitting the nucleus of cancer cells 2. Inhibit the growth and spread of cancer cells 3. To revitalize the entire network and spread of cancer cells 4. Improving the body's cells 5. Increase endurance and stamina MUST BE CONSIDERED! Ben Ca Lang cancer must be taken together with Ben Ca Lang Angion Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 31. 31 HERBS HERBAL HERBAMED "BENCALANG" ANTI CANCER /HERBAL HERBAMED "BENCALANG" ANTI CANCER / TUMORTUMOR 11 Pack Contains 2 Bottle @ 50 capsules @ 250mg Permit BPOM: POM TR. 103 310 911 In 1 Package Ben Ca Lang, there are two bottles of herbal capsules Ben Ca Lang Herbamed MUST BE CONSIDERED! Ben Ca Lang cancer must be taken together with Ben Ca Lang Angion Ben Ca Lang Angion Composition Each capsule contains extracts: 1.) Arecha catechu 50 mg 2.) Phyllanthus urinary 38 mg 3.) Catharanthus roseus 50 mg 4.) Ganoderma Lucidum 38 mg 5.) Eleuthorine Americana 74 mg property 1. Stopping the formation of new blood vessels, without blood cells, tumor cells / cancer will die 2. Destroying cancer cells 3. Preventing the cancer cell division 4. Inhibits cancer cell growth 5. Strengthening the immune system How to use 3 x 3 capsules / day. 30 minutes before meals (Price Rp. 175.000,-) Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 32. 32 HERBS ALBIMOR Al Biruni (Herbs for Cancer / Tumor)ALBIMOR Al Biruni (Herbs for Cancer / Tumor) Contents: 50 Capsules Permit BPOM: POM TR. 103 309 941 COMPOSITION: • Nigella sativa, Selaginella doederleinii, Hedyotis corymbosa, Andrographis paniculata, etc. Recommendation: Reduce consumption of bean sprouts, longan, jackfruit, MSG, durian, tape, pineapple, soft drinks, ice, chicory, kale, chili, salt, salted fish, and avoid alcohol. Not for pregnant women and children DESCRIPTION: Benefits: • Killing cancer cells • Inhibit the growth of cancer cells • Increase endurance • Reduces pain from cancer • Strengthening the tissue cells around the cancer • Reducing the adverse effects of chemotherapy Rp. 69.100,- Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 33. 33 HERBS GARLIC OIL CAPSULES (OIL ONION)GARLIC OIL CAPSULES (OIL ONION) Composition: Made from 100% garlic oil Contents: 60 capsules MOH license: No. IKOT 442/1077-KES / V / 10 Which has properties as: • Helps boost immunity • Overcoming headaches • Overcoming fever • Flu • Indigestion • Antiseptic • Antibiotics • Antimicrobials • Stroke • Heart • Anti-tumor / cancer • Potent Antioxidant... Price Rp. 61.000,- Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  • 34. 34 References Advisory Committee on Immunization Practices. ACIP provisional recommendations for the use of quadrivalent HPV vaccine. August 14, 2006. Accessed from http://www.cdc.gov/nip/recs/provisional_recs/hpv.pdf. American Cancer Society. Cancer facts and figures 2003. Atlanta (GA): ACS 2003. Available at http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Apgar BS, et al. “The 2001 Bethesda System Terminology.” Am Fam Physician. 2003;68:1992–1998. Cannistra SA, Niloff JM. “Cancer of the Uterine Cervix.” N Engl J Med. 1996;334:1030–1038. Cates W Jr, and the American Social Health Association Panel. “Estimates of the incidence and prevalence of sexually transmitted diseases in the United States.” Sex Transm Dis. 1999;26(suppl):S2–S7. Centers for Disease Control and Prevention. Rockville, Md: CDC National Prevention Information Network; 2004. Cervical Cytology Screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003; 102:417-27. Cox. Baillière’s Clin Obstet Gynaecol. 1995;9:1. Ferris et al. Modern Colposcopy: Textbook and Atlas. 2nd ed. Dubuque, Iowa: Kendall/Hunt; 2004: 2-4, 49, 78-82. Howley PM. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia, Pa: Lippincott-Raven; 2001:2197–2229. Human Papillomavirus. ACOG Practice Bulletin No. 61. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005; 105: 905-18. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006; 108: 699-705. Hutchinson ML. et al. “Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor.” Am J Clin Pathol. 1994; 101:215-219. Jansen KU, Shaw AR. ”Human Papillomavirus Vaccines and prevention of cervical cancer.” Annu Rev Med. 2004;55:319– 331. Kodner CM, Nasraty S. “Management of genital warts.” Am Fam Physician. 2004;70:2335–2342. Lacey CJN. “Therapy for genital human papillomavirus-related disease.” J Clin Virol. 2005;32(suppl):S82–S90. Linder J. et al. “ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.”Arch Pathol Lab Med. 1998; 122: 139-144. Management of Abnormal Cervical Cytology and Histology. ACOG Practice Bulletin No. 66. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005; 106: 645-64. Maw RD, Reitano M, Roy M. “An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle.” Int J STD AIDS. 1998;9:571–578.
  • 35. 35 References (Cont.) McCrory DC, Matchar DB, Bastian L, et al. Evaluation of Cervical Cytology. Evidence Report/Technology Assessment No. 5. AHCPR Publication No. 99-E010. Rockville, MD: Agency for Health Care Policy and Research. February 1999. Moscicki, A.B. et al. “Updating the natural history of HPV and anogenital cancer.” Vaccine. 2006; 24S3; 42-51. Munoz et al. “Epidemiologic classification of human papillomavirus types associated with cervical cancer.” N Engl J Med. 2003;348:518. Ostor, AG. “Natural history of cervical intraepithelial neoplasia: a critical review.” Int J Gynecol Pathol 1993; 12(2): 186- 92. Parkin DM, Bray F, Ferlay J, Pisani P. “Global cancer statistics 2002.” CA Cancer J Clin 2005; 55:74-108. Ries et al. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 1973-1997. 2000. Saslow D et al. “American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer.” CA Cancer J Clin. 2002;52:342-362. Schiffman M, Castle PE. “Human papillomavirus: Epidemiology and public health.” Arch Pathol Lab Med. 2003;127:930–934. Schiffman M ASCCP 2002 Biennial Orlando, Fl. Sellors et al. “Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada.” CMAJ. 2000;163:503-8. Smith, RA et al. “American Cancer Society Guidelines for the Early Detection of Cancer, 2003.” Cancer. 2003;53(1): 27-43. Solomon D, Davey D, Kurman R, et al, for the Forum Group Members and the Bethesda 2001 Workshop. JAMA. 2002;287:2114–2119. Soper DE. In: Berek JS, ed. Novak’s Gynecology. 13th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:453– 470. Spitzer M, Johnson C. Philadelphia, Pa: WB Saunders Co; 2002:41–72. Wiley DJ, Douglas J, Beutner K, et al “External genital warts: diagnosis, treatment and prevention.” Clin Infect Dis. 2002;35(suppl 2):S210–S224. Winer RL et al. “Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students.” Am J Epidemiol. 2003; 157:218-226. Wright, T.C. et al. “2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities.” JAMA. 2002; 287: 2120-2129. USPSTF. 2003. Available at http://www.ahrq.gov/clinic/uspstf/uspscerv.htm.
  • 36. 36 Questions? Program sponsored by Middle Earth Slide set developed with help from Dr. Kim Noyes Preventive Medicine Resident, School of Public Health Information provided by the New York State Department of Health, Cancer Services Program Please take a few momentsPlease take a few moments to complete the evaluation!to complete the evaluation!

Editor's Notes

  1. Key Point There are many different types of HPV; of the 15–20 oncogenic types, HPV 16 and HPV 18 account for the majority of cervical cancers. The disease burden is large. HPV is very prevalent, especially among young sexually active teens and adults. Background Papillomaviruses such as HPV are nonenveloped, double-stranded DNA viruses. More than 100 HPV types have been detected, with >80 types sequenced and classified. Approximately 30–40 types of HPV are anogenital, of which 15–20 types are oncogenic. HPV Types 16 and 18 are oncogenic and account for about two thirds of all cervical cancers. HPV Types 6 and 11 are nononcogenic and are associated with external anogenital warts and RRP. References 1. Schiffman M, Castle PE. Human papillomavirus: Epidemiology and public health. Arch Pathol Lab Med. 2003;127:930–934. 2. Wiley DJ, Douglas J, Beutner K, et al. External genital warts: Diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35(suppl 2):S210–S224.
  2. The causal role of human papillomavirus in all cancers of the cervix has been firmly established biologically and epidemiologically. Reference: Munoz, N. et al. “HPV in the etiology of human cancer.” Vaccine 24S3 2006;24S3: 1-10.
  3. Low-risk HPV types, such as types 6 and 11, most commonly cause benign low-grade cervical changes and genital warts. Types 16 and 18 and other “high-risk” HPV types are the most common cause of low-grade cervical cell abnormalities, and almost exclusively cause high-grade cervical cell abnormalities that are precursors to invasive cervical cancer and other lower genital tract malignancies including vulvar, vaginal, penile and anal cancer. The large IARC study of cervical cancers around the world demonstrated that over 90% of all of cervical cancers were associated with high-risk types of HPV Irrespective of geographical area 43% to 65% of the cancers were associated with HPV 16 8% to 31% were associated with HPV 18. Taken together, HPV 16 and 18 accounted for approximately two-thirds of all invasive cancers from all geographic areas. References: 1. Cox. Baillière’s Clin Obstet Gynaecol. 1995;9:1.2. Munoz et al. N Engl J Med. 2003;348:518.
  4. HPV is implicated as the cause of cervical cancer and many other ano-genital cancers. Reference: Parkin DM, Bray F, Ferlay J, Pisani P. “Global cancer statistics 2002.” CA Cancer J Clin 2005; 55:74-108.
  5. Genital HPV is transmitted sexually. Transmission occurs through contact with infected genital skin, mucous membranes, or body fluids from a partner with either overt or subclinical HPV infection. Other modes include oro-genital, manual-genital, and nonpenetrative genital-genital contact. Covering infected areas with a latex condom provides theoretical protection from infection. Areas not covered by condom can transmit HPV infection. Infrequently transmitted in the neonatal period, although published studies are conflicting. Most HPV infections are transient and are cleared by the immune system 70-90% will clear within 1-2 years Persistent HPV viral infections may lead to cancer and its precursors No treatment for HPV infection but cervical changes and warts CAN be treated Reference: Human Papillomavirus. ACOG Practice Bulletin No. 61. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005; 105: 905-18.
  6. Co-factors to HPV in cervical carcinogenesis may act in at least 3 ways: By influencing the acquisition of HPV infection (OCPs, multiparity) By increasing the risk of HPV persistence (HIV, immunosuppresion) By increasing the risk of progression from HPV infection to CIN 2,3 and cancer (smoking, multiparity) Cigarette smoking is a significant and independent risk factor for the development of CIN3 and SCC of cervix, increasing RR 2-5 fold. Risk increases with increased intensity and duration of smoking. Mechanism is likely that tobacco containing carcinogens promote neoplastic progression in HPV infected cells. HIV and other immunosupression cause an inability to clear HPV, increasing susceptibility to HPV and oncogenicity. Multiparity has been found to be associated with both cervical cancer and CIN3 with risk rising with increased number of pregnancies. Effect is independent of sexual behavior and socioeconomic variables. Pregnancy-induced alterations in nutritional status, the effects of hormones on the cervix or on HPV expression, increased susceptibility to potential mutagens or effect of trauma at delivery are proposed mechanisms. OCP use conveys a measurable increase in risk for SCC. The strongest evidence comes from an IARC multicenter case-control study demonstrating only a moderate association with cancer risk. Mechanism appears to be the physiologic effects such as eversion of the columnar epithelium, thus activating HPV-vulnerable immature squamous metaplasia. Reference: Ferris et al. Modern Colposcopy. 2004: 2-4, 78-82..
  7. This graph shows HPV prevalence and cervical cancer incidence as a function of a woman’s age. Key observations In younger women, there is a high prevalence of HPV infection but that cervical cancer is very rare. As women age, the prevalence of HPV declines and the incidence of cancer increases. Women over 30 years of age have a greater risk for developing high-grade lesions and cancer. Women with persistent high-risk HPV infections are the population most at-risk for having or developing cervical cancer. References: 1. Sellors et al. CMAJ. 2000;163:503. 2. Ries et al. Surveillance, Epidemiology and End Results (SEER) Cancer Stats NCI, 1973-1997. 2000. **Note: Data from the CMAJ study was collected from women aged 15-49, whereas the SEER data reported cancer incidence in all age-segments of the population.
  8. In summary Most will get HPV at some time during their lifetime Most, even with high-risk HPV, will clear or permanently suppress the virus. However, some do not. It is persistence of high-risk HPV that can lead to true pre-cancer Long persistence of high-risk HPV and HPV-induced CIN3 are necessary for the accumulation of random mutations that lead to cancer.
  9. Primary cervical cancer screening essentially began with the introduction of the Pap Smear. Introduced in the 1940’s, by Dr. George N. Papanicolaou, the pap smear eventually became the standard screening test for cervical cancer and pre-malignant lesions. The Pap test is based on a relatively simple principle. Cells from squamous epithelium exfoliate over time. Thus, the cells removed for cytologic examination represent epithelial cells, normal or abnormal, found at the surface. Widespread use of the pap smear has decreased cervical cancer deaths by 70%. Reference: Ferris et al. Modern Colposcopy. 2004: 2-4, 49.
  10. Cervical cytology screening is, in many respects, the ideal screening test. Cervical cancer has a defined premalignant phase of many years, which allows repeated tests to significantly reduce the impact of individual false-negative test results. Cervical cytology is inexpensive and is readily accepted among American women. However, cervical cytology, is not a diagnostic test. The sensitivity of the pap smear is low (ranges from 47-85%) and the specificity is high (95-98%). Reference: Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
  11. In 1996, the FDA approved the first of two currently available liquid-based thin-layer cytology preparations for cervical screening. Liquid-based thin-layer cervical cytology was introduced to help reduce the potential sampling errors. The Thin-Prep method appears to have increased sensitivity for detecting cancer precursor lesions over the conventional method, but the degree to which sensitivity is increased is unknown. The reported increase in sensitivity may make this method especially useful in women who are screened infrequently (fewer false negatives). The difference in specificity between the liquid-based and conventional tests has not been determined. Although an increase in sensitivity will permit earlier detection of cancer precursor lesions, any decrease in specificity can result in increased cost and morbidity from false-positive diagnoses. Both the conventional test and the liquid-based thin-layer test can be effective in population screening. Providers selecting a cervical cytology method should consider the screening history of their patient, the cost of the test, and the possible effects of false-negative or false-positive results. Reference: ACOG Practice Bulletin. Cervical Cytology Screening. 2003; 45:1-11.
  12. The next several slides will review the newest guidelines for cervical cancer screening from the American Cancer Society, the United States Preventive Services Task Force and the American College of Obstetricians and Gynecologists. These guidelines specifically state how often screening should be done, when to initiate screening and when screening can be discontinued. Reference: Cervical Cytology Screening. ACOG Practice Bulletin No. 45. 2003; 102:417-27.
  13. Key points: The only currently available, FDA approved HPV vaccine is Gardasil, manufactured by Merck. It is a quadrivalent vaccine, effective against 4 HPV types: 6, 11, 16, and 18. Highly efficacious Only approved for use in females 9-26 years old. $120/dose plus cost of administering/physician charge, etc. Reference: Cancer 2003;53(1): 27-43.
  14. Important points: Vaccination recommended for all females 9-26 years old. Vaccine is most effective if administered before sexual activity ACOG supports vaccination at 13-15 years of age during first visit to GYN The vaccine can be given to women with previous CIN, abnormal cytology or genital warts, but it is not intended to treat these patients. Patients with these conditions should undergo the appropriate evaluation and treatment. Women with suppressed immune systems can be vaccinated, although protection may be less than that of women with normal immune function. Pap screening recommendations remain the same. The vaccine is a preventive tool and is not a substitute for cancer screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  15. Important Points: Vaccination of women over age 26 and of males is not currently recommended. Pregnant women should not be vaccinated. The FDA classifies it as pregnancy category B. Although its use in pregnancy is not recommended, no teratogenic effects have been reported in animal studies. In clinical studies, the proportion of pregnancies with an adverse outcome were comparable in women who received the quadrivalent HPV vaccine and in women who received a placebo. If a woman discovers she is pregnant during the vaccine schedule, she should delay finishing the series until after she gives birth. The manufacturer’s pregnancy registry should be contacted if pregnancy is detected during the vaccination schedule. It is unclear whether vaccine can be provided to women who are breastfeeding because inactivated vaccines do not affect the safety of breastfeeding for mothers or infants. It is not known whether vaccine antigens or antibodies found in the quadrivalent vaccine are excreted in human milk. ACOG and ACIP state that lactating women can receive the vaccine. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  16. The Advisory Council on Immunization Practices has recommended the initial vaccination target of females aged 11 or 12. This is part of the “adolescent platform” that supports a routine well-child check at age 11-12 that would include discussion of HPV vaccine and other recommended immunizations (DTaP and Meningitis). In summary The earlier the vaccine is given, the better Continue cervical cytology screening Vaccine is prophylactic, not treatment Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  17. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  18. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  19. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  20. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  21. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  22. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  23. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.
  24. Health care providers are encouraged to discuss with their patients the benefits and limitations of the quadrivalent HPV vaccine and the need for continued routine cervical cytology screening. Reference: Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. 2006; 108: 699-705.